A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.
A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon Pharmaceuticals’ investigational immunosuppression therapy tegoprubart in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results